Retention of transporter activities in cryopreserved, isolated rat hepatocytes.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Drug Metabolism And Disposition

• Publication date

  2003-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/DMD.31.4.447PMID 12642471
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of 17β-Estradiol-d-17β-Glucuronide on the Rat Organic Anion Transporting Polypeptide 2-Mediated Transport Differs Depending on Substrates

  2002cited by this paper
• Effect of 17 beta-estradiol-D-17 beta-glucuronide on the rat organic anion transporting polypeptide 2-mediated transport differs depending on substrates.

  2002cited by this paper
• Transport of the sulfated, amidated bile acid, sulfolithocholyltaurine, into rat hepatocytes is mediated by Oatp1 and Oatp2

  2002cited by this paper
• Role of transport proteins in drug absorption, distribution and excretion

  2001cited by this paper
• Drug-Drug Interactions Involving the Membrane Transport Process

  2001cited by this paper
• Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3

  2001influential reference
• Characterization and inhibition by a wide range of xenobiotics of organic anion excretion by primary human hepatocytes.

  2000influential reference
• Uptake of enalapril and expression of organic anion transporting polypeptide 1 in zonal, isolated rat hepatocytes.

  2000cited by this paper
• CRYOPRESERVED PRIMARY HEPATOCYTES AS A CONSTANTLY AVAILABLE IN VITRO MODEL FOR THE EVALUATION OF HUMAN AND ANIMAL DRUG METABOLISM AND ENZYME INDUCTION*

  2000cited by this paper
• Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential.

  1999cited by this paper
• Hepatobiliary transport governs overall elimination of peptidic endothelin antagonists in rats.

  1999cited by this paper
• Effect of cryopreservation on cytochrome P-450 enzyme induction in cultured rat hepatocytes.

  1999cited by this paper
• Biliary excretion in primary rat hepatocytes cultured in a collagen-sandwich configuration.

  1999cited by this paper
• Polyspecific substrate uptake by the hepatic organic anion transporter Oatp1 in stably transfected CHO cells.

  1999cited by this paper
• Carrier-mediated hepatic uptake of peptidic endothelin antagonists in rats.

  1999cited by this paper
• Lack of zonal uptake of estrone sulfate in enriched periportal and perivenous isolated rat hepatocytes.

  1999cited by this paper
• Polyspecific substrate uptake by the hepatic organic anion transporter Oatp1 in stably transfected CHO cells.

  1999cited by this paper
• Drug metabolizing capacity of cryopreserved human, rat, and mouse liver parenchymal cells in suspension.

  1999cited by this paper
• Description of a 96-well plate assay to measure cytochrome P4503A inhibition in human liver microsomes using a selective fluorescent probe.

  1999cited by this paper
• Induction of cytochrome-P450 in cryopreserved rat and human hepatocytes.

  1999cited by this paper
• Characterization of the uptake of rocuronium and digoxin in human hepatocytes: carrier specificity and comparison with in vivo data.

  1998cited by this paper
• Partial Maintenance of Taurocholate Uptake by Adult Rat Hepatocytes Cultured in a Collagen Sandwich Configuration

  1998cited by this paper
• Uptake of taurocholic acid in human hepatocytes isolated from livers of donors of different age.

  1998cited by this paper
• Hepatobiliary elimination of cationic drugs: The role of P-glycoproteins and other ATP-dependent transporters

  1997cited by this paper
• Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver.

  1996influential reference
• Xenobiotic metabolizing enzyme activities and viability are well preserved in EDTA-isolated rat liver parenchymal cells after cryopreservation.

  1995cited by this paper
• Redistribution of canalicular organic anion transport activity in isolated and cultured rat hepatocytes

  1995cited by this paper
• Expression cloning of a rat liver Na(+)-independent organic anion transporter.

  1994cited by this paper
• Drug excretion mediated by a new prototype of polyspecific transporter

  1994cited by this paper
• Uptake and metabolism of vinca alkaloids by freshly isolated human hepatocytes in suspension.

  1994cited by this paper
• Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter.

  1994cited by this paper
• Characterization of transport in isolated human hepatocytes. A study with the bile acid taurocholic acid, the uncharged ouabain and the organic cations vecuronium and rocuronium.

  1994cited by this paper
• Parallel decrease of Na+ ‐taurocholate cotransport and its encoding mRNA in primary cultures of rat hepatocytes

  1993cited by this paper
• Preservation of the rate and profile of xenobiotic metabolism in rat hepatocytes stored in liquid nitrogen.

  1993cited by this paper
• Carrier-mediated transport in the hepatic distribution and elimination of drugs, with special reference to the category of organic cations

  1990cited by this paper
• Tolbutamide hydroxylation by human liver microsomes. Kinetic characterisation and relationship to other cytochrome P-450 dependent xenobiotic oxidations.

  1988cited by this paper
• High-performance liquid chromatographic assays for bufuralol 1'-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P-450 isozymes of human liver.

  1987cited by this paper
• Mechanism of chemical-induced toxicity. I. Use of a rapid centrifugation technique for the separation of viable and nonviable hepatocytes.

  1985cited by this paper
• [4] Isolation and use of liver cells

  1978influential reference
• Isolation and use of liver cells.

  1978cited by this paper

• Hepatocellular Metabolic Profile: Understanding Post-Thawing Metabolic Shift in Primary Hepatocytes In Vitro

  2025cites this paper
• Canadian Content in the Pages of Drug Metabolism and Disposition: A Comprehensive Historical Analysis

  2023cites this paper
• Liver toxicity of anthraquinones: A combined in vitro cytotoxicity and in silico reverse dosimetry evaluation.

  2020cites this paper
• Effect of Cryopreservation on Enzyme and Transporter Activities in Suspended and Sandwich Cultured Rat Hepatocytes

  2018cites this paper
• Sandwich-Cultured Hepatocytes for Mechanistic Understanding of Hepatic Disposition of Parent Drugs and Metabolites by Transporter–Enzyme Interplay

  2018cites this paper
• Application of Model-Based Approaches to Evaluate Hepatic Transporter-Mediated Drug Clearance: In vitro, In vivo, and In vitro-In vivo Extrapolation.

  2016cites this paper
• The Impact of Solute Carrier (SLC) Drug Uptake Transporter Loss in Human and Rat Cryopreserved Hepatocytes on Clearance Predictions

  2014cites this paper
• DMD055947 407..414

  2014cites this paper
• Generating an In Vitro–In Vivo Correlation for Metabolism and Liver Enrichment of a Hepatitis C Virus Drug, Faldaprevir, Using a Rat Hepatocyte Model (HepatoPac)

  2014cites this paper
• In Vitro Methods to Support Transporter Evaluation in Drug Discovery and Development

  2013cites this paper
• Transporter study methodologies

  2013cites this paper
• Analysis of Hepatic Transport Proteins

  2013cites this paper
• Primary hepatocyte cultures as prominent in vitro tools to study hepatic drug transporters

  2013cites this paper
• Preclinical experimental models of drug metabolism and disposition in drug discovery and development

  2012cites this paper
• Permeability and Transporter Models in Drug Discovery and Development

  2012cites this paper
• Effect of cryopreservation on the activity of OATP1B1/3 and OCT1 in isolated human hepatocytes.

  2011cites this paper
• The identification of 4,7-disubstituted naphthoic acid derivatives as UDP-competitive antagonists of P2Y14.

  2011cites this paper
• Pharmacokinetics of Cefovecin in squirrel monkey (Saimiri sciureus), rhesus macaques (Macaca mulatta), and cynomolgus macaques (Macaca fascicularis).

  2010cites this paper
• Effect of prototypical inducers on ligand activated nuclear receptor regulated drug disposition genes in rodent hepatic and intestinal cells

  2010cites this paper
• Evaluation of the human prediction of clearance from hepatocyte and microsome intrinsic clearance for 52 drug compounds

  2010cites this paper
• Evaluation of drug transporter interactions in drug discovery and development.

  2010cites this paper
• An optimised method for cryopreservation of human hepatocytes.

  2009cites this paper
• Comparison of intrinsic metabolic clearance in fresh and cryopreserved human hepatocytes

  2009cites this paper
• Metabolic Activity of Cytochrome P450 Isoforms in Hepatocytes Cryopreserved with Wheat Protein Extract

  2008cites this paper
• Application of pharmacokinetic theory to examine roles of transporters and enzymes in intestinal and hepatic drug disposition.

  2008cites this paper
• Evaluation of Cryopreserved Human Hepatocytes as an Alternative in Vitro System to Microsomes for the Prediction of Metabolic Clearance

  2007cites this paper
• Evidence of Oatp and Mdr1 in cryopreserved rat hepatocytes.

  2007cites this paper
• Prediction of human pharmacokinetics—evaluation of methods for prediction of hepatic metabolic clearance

  2007cites this paper
• Compositions cellulaires et procédé permettant de les préparer

  2006cites this paper
• Use of Cryopreserved Human Hepatocytes in Sandwich Culture to Measure Hepatobiliary Transport

  2006cites this paper
• Compositions cellulaires et leurs procédés de préparation

  2006cites this paper
• Distribution – Across Barriers

  2006cites this paper
• Human and animal hepatocytes in vitro with extrapolation in vivo.

  2004cites this paper
• Impact of serum on clearance predictions obtained from suspensions and primary cultures of rat hepatocytes.

  2004cites this paper
• Evaluating the use of cryopreserved hepatocytes for the prediction of in vivo hepatic clearance

  2004cites this paper
• tools for the prediction of metabolic clearance

  2004influential citation
• EVALUATION OF FRESH AND CRYOPRESERVED HEPATOCYTES AS IN VITRO DRUG METABOLISM TOOLS FOR THE PREDICTION OF METABOLIC CLEARANCE

  2004influential citation
• Serum-free cryopreservation of porcine hepatocytes

  2004cites this paper
• Cryopreservation and gel collagen culture of porcine hepatocytes.

  2004cites this paper
• Special Section on Transporters in Drug Disposition and Pharmacokinetic Prediction Sandwich-Cultured Hepatocytes for Mechanistic Understanding of Hepatic Disposition of Parent Drugs and Metabolites by Transporter – Enzyme Interplay s

  year unknowncites this paper